Electroweak radiative corrections to triple photon production at the ILC

In this paper, we present the precision predictions for three photon production in the standard model (SM) at the ILC including the full next-to-leading (NLO) electroweak (EW) corrections, high order initial state radiation (h.o.ISR) contributions and beamstrahlung effects. We present the LO and the NLO EW+h.o.ISR+beamstrahlung corrected total cross sections for various colliding energy when $\sqrt s \ge 200 {\rm GeV}$ and the kinematic distributions of final photons with $\sqrt s = 500 {\rm GeV}$ at ILC, and find that the NLO EW corrections, the h.o.ISR contributions and the beamstrahlung effects are important in exploring the process $e^+e^- \to \gamma\gamma\gamma$.Comment: 6 pages, 8 figures, accepted for publication in Physics Letters

Synthesis, Structure, and Catalytic Activity of A New Mn(II) Complex with 1,4-Phenylenediacetic Acid and 1,10-Phenanthroline

A new Mn(II) complex material has been synthesized by one-pot reaction of Mn(CH3COO)2·4H2O, 1,4-phenylenediacetic (H2L), 1,10-phenanthroline (phen), and NaOH in water/ethanol (v:v = 1:1) solution. The structure of Mn(II) complex was determined by elemental analysis, FTIR, and X-ray single-crystal diffraction analysis. The results reveal that Mn(II) complex was constructed by a monodentate 1,4-phenylenediacetate ligand, two phen ligands, a coordinated water molecule, 0.5 uncoordinated 1,4-phenylenediacetate ligand and six uncoordinated water molecules. The complex molecules form 1D chain structure by the π-π interaction of phen molecules. The catalytic activity of Mn(II) complex for coupling of benzaldehyde, phenylacetylene and piperidine in 1,4-dioxane has also been  investigated  and the maximum yield of propargylamine is up to 72.2 % after 12 h at 120 oC.

Determination of cyclovirobuxine D in human plasma by liquid chromatography tandem mass spectrometry and application in a pharmacokinetic study

AbstractA sensitive and reliable method based on liquid chromatography tandem mass spectrometry (LC–MS/MS) for the quantitation of cyclovirobuxine D in human plasma has been developed and validated. Sample preparation by solid phase extraction was followed by separation on a CN column with a mobile phase of methanol–water (95:5, v/v) containing 0.2% formic acid. Mass spectrometric detection in the positive ion mode was carried out by selected reaction monitoring (SRM) of the transitions at m/z 403.0→372.0 for cyclovirobuxine D and m/z 325.0→234.0 for citalopram (internal standard). The method was linear in the range 10–200ng/L with LLOQ of 10ng/L, recovery >85%, and no significant matrix effects. Intra- and inter-day precisions were all <9% with accuracies of 94.0–104.8%. The method was successfully applied to a pharmacokinetic study involving a single oral administration of a 2mg cyclovirobuxine D tablet to twenty-two healthy Chinese volunteers